January 16, 2024
A vaccine for Staphylococcus aureus, one of the most common bacterial infections, would be a game changer for public health. No vaccine candidates have succeeded in clinical trials, but nobody knows why. Researchers at UC San Diego may have figured it out.
December 17, 2020
…to receive the COVID-19 vaccine—at 8:38 a.m. on Wednesday. Ending the Pandemic Begins Now A Statement by Patty Maysent, CEO, UC San Diego Health These are momentous days, though too often darkened by rising rates of COVID-19 transmission, reports of overstressed hospitals, increasing sickness and mortality. But now, we are…
June 29, 2021
UC San Diego Health is now offering a verifiable digital vaccine record to its patients who have or will receive a COVID-19 vaccine. These secure online records, otherwise known as a SMART health card, can be accessed directly from the MyUCSDChart patient portal.
March 11, 2021
Q&A: Are COVID-19 Vaccines Safe and Effective? Nearly one year ago, on March 13, 2020, San Diego County issued a two-week stay-at-home order to slow the spread of the COVID-19 pandemic. The gravity of the situation was growing quickly. Within nine months, the first vaccines were offered to health care…
May 13, 2021
…A Push to Inoculate Vaccination Disparity New UC San Diego biologist endeavors to communicate the safety and life-saving importance of COVID-19 vaccination in underserved communities A first-generation university student and the son of Mexican immigrants, Assistant Professor Fabian Rivera-Chávez was born and raised in Northern California. He joined UC San…
April 7, 2016
…“Mesa Consortium,” a new scientific hub for the Human Vaccines Project. Under a collaborative agreement, the Mesa Consortium and the Human Vaccine Project aim to transform current understanding of the human immune system and expedite development of vaccines and biologics to prevent and treat many global diseases.
July 28, 2022
Health care facilities in Black metropolitan counties, Hispanic rural counties and hardest-hit counties were less likely to administer COVID-19 vaccines during initial rollout, UC San Diego study finds.
April 6, 2022
UC San Diego has joined a Phase II clinical trial to evaluate various additional COVID-19 booster shots. The trial seeks to understand if different vaccine regimens can broaden immune responses in adults who already have received a primary vaccination series and a first booster shot.
March 14, 2022
Financial incentives and other nudges have been used to help increase vaccination rates across the nation, but new research from the University of California San Diego’s Rady School of Management reveals that compensations need to be large—at least $100—to reduce vaccine hesitancy.
May 20, 2021
Moores Cancer Center at UC San Diego Health joins other National Cancer Institute cancer centers in urging that HPV vaccinations get back on track as part of cancer prevention. Don’t delay. Save lives.
